Snap Denied Review of Fentanyl Deaths Case by California Court

December 6, 2024, 1:02 AM UTC

Snap Inc. will have to defend a lawsuit alleging it facilitated the sale of fentanyl-laced pills that caused the death of eight of its users after a California state appeals court on Thursday declined to review the case.

The Los Angeles-based maker of the messaging app Snapchat had petitioned California’s Second District Court of Appeals to review a trial court ruling from January finding that the tech industry’s immunity law known as Section 230 doesn’t block the lawsuit.

The appeals court denied Snap’s petition without issuing a written explanation.

Around a dozen parents whose children had used Snapchat to purchase ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.